| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.088 | 0.003 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.005 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.006 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |